ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,941.75
0.14%
S&P 500
5,667.20
0.64%
Dow Jones
40,954.48
1.85%
US Dollar vs Yen
158.342
0.12%
Brent Oil
83.255
-1.29%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. RespireRx Pharmaceuticals Inc (PK) (RSPI)

  7. RespireRx Pharmaceuticals Inc (PK) (RSPI) ニュース

RSPI

RespireRx Pharmaceuticals (PK) (RSPI)

RespireRx Pharmaceuticals Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:RSPI
日付受信時刻ニュースソース見出しコード企業名
2020/12/0123 : 24Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/11/2523 : 21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/11/2421 : 52Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/11/2407 : 32Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/11/1623 : 15Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/11/1223 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/10/3100 : 19Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/10/2919 : 07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/10/2906 : 19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/10/2105 : 31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/10/1419 : 48Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/10/0605 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/10/0304 : 47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/09/2606 : 17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/09/1605 : 22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/2004 : 42Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/1423 : 52Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/1302 : 14Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/1301 : 30Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/0519 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/0503 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/0503 : 27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/0503 : 16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/08/0406 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/07/1607 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/07/0806 : 02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/06/2703 : 36Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/06/1205 : 54Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/05/2105 : 54Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/05/1605 : 40Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:RSPI

最近閲覧した銘柄

NYSE
AXP
American Express
FX
USDEUR
US Dollar vs Euro
SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
CCOM
US500
US 500
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
GOOGL
Alphabet
USOTC
ADDYY
Adidas (QX)
NYSE
MCD
McDonalds
NYSE
VZ
Verizon Communications
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有